Five‐year risk of incident disease following a diagnosis of chronic rhinosinusitis
Allergy2015Vol. 70(12), pp. 1613–1621
Citations Over TimeTop 10% of 2015 papers
Annemarie G. Hirsch, Xiaowei Yan, Agnes S. Sundaresan, Bruce K. Tan, Robert P. Schleimer, Robert C. Kern, T. L. Kennedy, J. Scott Greene, Brian S. Schwartz
Abstract
The risk of other diseases associated with CRS adds to the burden of an already highly burdensome condition, and suggests either that CRS promotes onset of other diseases or is an indicator of systemic disease processes. Different patterns of association with diseases by CRS phenotype may be due to CRSwNP sample size limitations or reflect a different pattern of disease onset by phenotype. These findings have implications for screening guidelines and care of CRS patients.
Related Papers
- → EUFOREA expert board meeting on uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) and biologics: Definitions and management(2020)333 cited
- → Chronic Rhinosinusitis with Nasal Polyps(2019)173 cited
- → Nasal IL-25 predicts the response to oral-corticosteroid in chronic rhinosinusitis with nasal polyps (CRSwNP)(2018)1 cited
- → [The perspectives of biologics in the treatment of chronic rhinosinusitis with nasal polyps].(2023)1 cited
- → Are type-2 biomarkers of any help in distinguishing chronic rhinosinusitis with nasal polyps from chronic rhinosinusitis without nasal polyps?(2022)